{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:54:06Z","timestamp":1792446846149,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hyponatremia (HN) is the most common electrolyte imbalance (defined as a serum sodium concentration Na(S) of\u00a0\u2009&lt;\u2009130\u00a0mmol\/l) and often induced by drugs including psychotropic drugs. AMSP (Arzneimittelsicherheit in der Psychiatrie) is a multicenter drug surveillance program that assesses severe or unusual adverse drug reactions (ADRs) occurring during treatment with psychotropic drugs. This study presents data from 462,661 psychiatric inpatients treated in participating hospitals between 1993 and 2016 and serves as an update of a previous contribution by Letmaier et al. (JAMA 15(6):739\u2013748, 2012). A total of 210 cases of HN were observed affecting 0.05% of patients. 57.1% of cases presented symptomatically; 19.0% presented with severe symptoms (e.g., seizures, vomiting). HN occurred after a median of 7\u00a0days following the first dose or dose increase. Incidence of HN was highest among the two antiepileptic drugs oxcarbazepine (1.661% of patients treated) and carbamazepine (0.169%), followed by selective serotonin-norepinephrine reuptake inhibitors (SSNRIs, 0.088%) and selective serotonin reuptake inhibitors (0.071%). Antipsychotic drugs, tricyclic antidepressants, and mirtazapine exhibited a significantly lower incidence of HN. The risk of HN was 16\u201342 times higher among patients concomitantly treated with other potentially HN-inducing drugs such as diuretic drugs, angiotensin-converting-enzyme inhibitors, angiotensin II receptor blockers, and proton pump inhibitors. Female SSNRI-users aged\u00a0\u2009\u2265\u200965\u00a0years concomitantly using other HN-inducing drugs were the population subgroup with the highest risk of developing HN. The identification of high-risk drug combinations and vulnerable patient subgroups represents a significant step in the improvement of drug safety and facilitates the implementation of precautionary measures.<\/jats:p>","DOI":"10.1007\/s00702-021-02369-1","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T05:23:51Z","timestamp":1625117031000},"page":"1249-1264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Psychotropic drug-induced hyponatremia: results from a drug surveillance program\u2013an update"],"prefix":"10.1007","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8678-7419","authenticated-orcid":false,"given":"Johanna","family":"Seifert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Letmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Deest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian K.","family":"Eberlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Bleich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Grohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sermin","family":"Toto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"issue":"6","key":"2369_CR1","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1001\/archinte.1974.00320240137019","volume":"134","author":"K Ajlouni","year":"1974","unstructured":"Ajlouni K, Kern MW, Tures JF, Theil GB, Hagen TC (1974) Thiothixene-induced hyponatremia. Arch Intern Med 134(6):1103\u20131105. https:\/\/doi.org\/10.1001\/archinte.1974.00320240137019","journal-title":"Arch Intern Med"},{"issue":"12","key":"2369_CR2","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1111\/bcp.13741","volume":"84","author":"MA Bahar","year":"2018","unstructured":"Bahar MA, Kamp J, Borgsteede SD, Hak E, Wilffert B (2018) The impact of CYP2D6 mediated drug\u2013drug interaction: a systematic review on a combination of metoprolol and paroxetine\/fluoxetine. Br J Clin Pharmacol 84(12):2704\u20132715. https:\/\/doi.org\/10.1111\/bcp.13741","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"2369_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1176\/appi.psy.46.5.495","volume":"46","author":"JA Bourgeois","year":"2005","unstructured":"Bourgeois JA (2005) Reversible hyponatremia and venlafaxine. Psychosomatics 46(5):495\u2013496. https:\/\/doi.org\/10.1176\/appi.psy.46.5.495","journal-title":"Psychosomatics"},{"key":"2369_CR4","first-page":"188","volume":"24","author":"C Bullmann","year":"2016","unstructured":"Bullmann C (2016) Hyponatri\u00e4mie. Arzneimittelverordnung in Der Praxis 24:188\u2013194","journal-title":"Arzneimittelverordnung in Der Praxis"},{"key":"2369_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4551","volume":"343","author":"C Coupland","year":"2011","unstructured":"Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J (2011a) Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 343:d4551. https:\/\/doi.org\/10.1136\/bmj.d4551","journal-title":"BMJ"},{"issue":"28","key":"2369_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta15280","volume":"15","author":"CA Coupland","year":"2011","unstructured":"Coupland CA, Dhiman P, Barton G, Morriss R, Arthur A, Sach T, Hippisley-Cox J (2011b) A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database. Health Technol Assess 15(28):1\u2013202. https:\/\/doi.org\/10.3310\/hta15280","journal-title":"Health Technol Assess"},{"issue":"6","key":"2369_CR7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.psym.2014.01.010","volume":"55","author":"L De Picker","year":"2014","unstructured":"De Picker L, Van Den Eede F, Dumont G, Moorkens G, Sabbe BG (2014) Antidepressants and the risk of hyponatremia: a class-by-class review of literature. Psychosomatics 55(6):536\u2013547. https:\/\/doi.org\/10.1016\/j.psym.2014.01.010","journal-title":"Psychosomatics"},{"issue":"Suppl 1","key":"2369_CR8","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1055\/s-2004-815509","volume":"37","author":"D Degner","year":"2004","unstructured":"Degner D, Grohmann R, Kropp S, R\u00fcther E, Bender S, Engel RR, Schmidt LG (2004) Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry 37(Suppl 1):S39-45. https:\/\/doi.org\/10.1055\/s-2004-815509","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"2369_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.7861\/clinmedicine.17-3-263","volume":"17","author":"R Dineen","year":"2017","unstructured":"Dineen R, Thompson CJ, Sherlock M (2017) Hyponatraemia\u2014presentations and management. Clin Med 17(3):263\u2013269. https:\/\/doi.org\/10.7861\/clinmedicine.17-3-263","journal-title":"Clin Med"},{"issue":"2","key":"2369_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00406-017-0827-5","volume":"268","author":"K Druschky","year":"2018","unstructured":"Druschky K, Bleich S, Grohmann R, Engel RR, Kleimann A, St\u00fcbner S, Greil W, Toto S (2018) Use and safety of antiepileptic drugs in psychiatric inpatients-data from the AMSP study. Eur Arch Psychiatry Clin Neurosci 268(2):191\u2013208. https:\/\/doi.org\/10.1007\/s00406-017-0827-5","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"2369_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s11920-007-0025-7","volume":"9","author":"B Dundas","year":"2007","unstructured":"Dundas B, Harris M, Narasimhan M (2007) Psychogenic polydipsia review: etiology, differential, and treatment. Curr Psychiatry Rep 9(3):236\u2013241. https:\/\/doi.org\/10.1007\/s11920-007-0025-7","journal-title":"Curr Psychiatry Rep"},{"issue":"1","key":"2369_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/13651500500410216","volume":"10","author":"C Egger","year":"2006","unstructured":"Egger C, Muehlbacher M, Nickel M, Geretsegger C, Stuppaeck C (2006) A review on hyponatremia associated with SSRIs, reboxetine and venlafaxine. Int J Psychiatry Clin Pract 10(1):17\u201326. https:\/\/doi.org\/10.1080\/13651500500410216","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"3","key":"2369_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1001\/archinte.164.3.327","volume":"164","author":"TJ Fabian","year":"2004","unstructured":"Fabian TJ, Amico JA, Kroboth PD, Mulsant BH, Corey SE, Begley AE, Bensasi SG, Weber E, Dew MA, Reynolds CF, Pollock BG (2004) Paroxetine-induced hyponatremia in older adults: a 12-week prospective study. Arch Intern Med 164(3):327\u2013332. https:\/\/doi.org\/10.1001\/archinte.164.3.327","journal-title":"Arch Intern Med"},{"key":"2369_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.seizure.2018.04.025","volume":"59","author":"H Falhammar","year":"2018","unstructured":"Falhammar H, Lindh JD, Calissendorff J, Farmand S, Skov J, Nathanson D, Mannheimer B (2018) Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: a population-based case-control study. Seizure 59:28\u201333. https:\/\/doi.org\/10.1016\/j.seizure.2018.04.025","journal-title":"Seizure"},{"key":"2369_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejim.2018.11.011","volume":"60","author":"H Falhammar","year":"2019","unstructured":"Falhammar H, Lindh JD, Calissendorff J, Skov J, Nathanson D, Mannheimer B (2019a) Antipsychotics and severe hyponatremia: a Swedish population-based case-control study. Eur J Intern Med 60:71\u201377. https:\/\/doi.org\/10.1016\/j.ejim.2018.11.011","journal-title":"Eur J Intern Med"},{"key":"2369_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejim.2018.08.012","volume":"59","author":"H Falhammar","year":"2019","unstructured":"Falhammar H, Lindh JD, Calissendorff J, Skov J, Nathanson D, Mannheimer B (2019b) Associations of proton pump inhibitors and hospitalization due to hyponatremia: a population\u2013based case\u2013control study. Eur J Intern Med 59:65\u201369. https:\/\/doi.org\/10.1016\/j.ejim.2018.08.012","journal-title":"Eur J Intern Med"},{"issue":"10","key":"2369_CR17","doi-asserted-by":"publisher","first-page":"e3696","DOI":"10.1210\/clinem\/dgaa194","volume":"105","author":"H Falhammar","year":"2020","unstructured":"Falhammar H, Skov J, Calissendorff J, Nathanson D, Lindh JD, Mannheimer B (2020) Associations Between antihypertensive medications and severe hyponatremia: a Swedish population\u2013based case\u2013control study. J Clin Endocrinol Metab 105(10):e3696\u2013e3705. https:\/\/doi.org\/10.1210\/clinem\/dgaa194","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2369_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.amjmed.2017.07.025","volume":"131","author":"S Farmand","year":"2018","unstructured":"Farmand S, Lindh JD, Calissendorff J, Skov J, Falhammar H, Nathanson D, Mannheimer B (2018) Differences in associations of antidepressants and hospitalization due to hyponatremia. Am J Med 131(1):56\u201363. https:\/\/doi.org\/10.1016\/j.amjmed.2017.07.025","journal-title":"Am J Med"},{"issue":"1","key":"2369_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000089825","volume":"52","author":"JM Ferguson","year":"2006","unstructured":"Ferguson JM, Hill H (2006) Pharmacokinetics of fluoxetine in elderly men and women. Gerontology 52(1):45\u201350. https:\/\/doi.org\/10.1159\/000089825","journal-title":"Gerontology"},{"issue":"2","key":"2369_CR20","doi-asserted-by":"publisher","DOI":"10.12890\/2015_000341","volume":"3","author":"F Ferreira","year":"2016","unstructured":"Ferreira F, Mateus S, Santos AR, Moreira H, Ferreira NR (2016) Pantoprazole-related Symptomatic Hyponatremia. Eur J Case Rep Intern Med 3(2):000341. https:\/\/doi.org\/10.12890\/2015_000341","journal-title":"Eur J Case Rep Intern Med"},{"issue":"6\u20137","key":"2369_CR21","first-page":"686","volume":"24","author":"E Fort","year":"2000","unstructured":"Fort E, Laurin C, Baroudi A, Liebaert-Bories MP, Strock P (2000) Lansoprazole-induced hyponatremia. Gastroenterol Clin Biol 24(6\u20137):686","journal-title":"Gastroenterol Clin Biol"},{"key":"2369_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40697-016-0111-z","volume":"3","author":"S Gandhi","year":"2016","unstructured":"Gandhi S, McArthur E, Reiss JP, Mamdani MM, Hackam DG, Weir MA, Garg AX (2016) Atypical antipsychotic medications and hyponatremia in older adults: a population-based cohort study. Can J Kidney Health Dis 3:21. https:\/\/doi.org\/10.1186\/s40697-016-0111-z","journal-title":"Can J Kidney Health Dis"},{"issue":"7","key":"2369_CR23","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/qjmed\/hcn061","volume":"101","author":"F Gankam Kengne","year":"2008","unstructured":"Gankam Kengne F, Andres C, Sattar L, Melot C, Decaux G (2008) Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM 101(7):583\u2013588. https:\/\/doi.org\/10.1093\/qjmed\/hcn061","journal-title":"QJM"},{"issue":"4","key":"2369_CR24","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/ki.2012.459","volume":"83","author":"F Gankam-Kengne","year":"2013","unstructured":"Gankam-Kengne F, Ayers C, Khera A, de Lemos J, Maalouf NM (2013) Mild hyponatremia is associated with an increased risk of death in an ambulatory setting. Kidney Int 83(4):700\u2013706. https:\/\/doi.org\/10.1038\/ki.2012.459","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"2369_CR25","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1055\/s-2004-815505","volume":"37","author":"R Grohmann","year":"2004","unstructured":"Grohmann R, Engel RR, R\u00fcther E, Hippius H (2004) The AMSP drug safety program: methods and global results. Pharmacopsychiatry 37(Suppl 1):S4-11. https:\/\/doi.org\/10.1055\/s-2004-815505","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"2369_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00406-013-0419-y","volume":"264","author":"R Grohmann","year":"2014","unstructured":"Grohmann R, Engel RR, M\u00f6ller HJ, R\u00fcther E, van der Velden JW, St\u00fcbner S (2014) Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study. Eur Arch Psychiatry Clin Neurosci 264(2):131\u2013141. https:\/\/doi.org\/10.1007\/s00406-013-0419-y","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"1","key":"2369_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/15622970600960157","volume":"8","author":"B Holtschmidt-T\u00e4schner","year":"2007","unstructured":"Holtschmidt-T\u00e4schner B, Soyka M (2007) Hyponatremia-induced seizure during carbamazepine treatment. World J Biol Psychiatry 8(1):51\u201353. https:\/\/doi.org\/10.1080\/15622970600960157","journal-title":"World J Biol Psychiatry"},{"issue":"3","key":"2369_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1176\/ajp.146.3.399a","volume":"146","author":"AS Hwang","year":"1989","unstructured":"Hwang AS, Magraw RM (1989) Syndrome of inappropriate secretion of antidiuretic hormone due to fluoxetine. Am J Psychiatry 146(3):399. https:\/\/doi.org\/10.1176\/ajp.146.3.399a","journal-title":"Am J Psychiatry"},{"key":"2369_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.eplepsyres.2018.03.023","volume":"143","author":"T Intravooth","year":"2018","unstructured":"Intravooth T, Staack AM, Juerges K, Stockinger J, Steinhoff BJ (2018) Antiepileptic drugs-induced hyponatremia: review and analysis of 560 hospitalized patients. Epilepsy Res 143:7\u201310. https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.03.023","journal-title":"Epilepsy Res"},{"issue":"9","key":"2369_CR30","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1345\/aph.1G293","volume":"40","author":"S Jacob","year":"2006","unstructured":"Jacob S, Spinler SA (2006) Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults. Ann Pharmacother 40(9):1618\u20131622. https:\/\/doi.org\/10.1345\/aph.1G293","journal-title":"Ann Pharmacother"},{"issue":"3","key":"2369_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.seizure.2013.11.015","volume":"23","author":"YS Kim","year":"2014","unstructured":"Kim YS, Kim DW, Jung KH, Lee ST, Kang BS, Byun JI, Yeom JS, Chu K, Lee SK (2014) Frequency of and risk factors for oxcarbazepine-induced severe and symptomatic hyponatremia. Seizure 23(3):208\u2013212. https:\/\/doi.org\/10.1016\/j.seizure.2013.11.015","journal-title":"Seizure"},{"issue":"5","key":"2369_CR32","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/gps.367","volume":"16","author":"D Kirby","year":"2001","unstructured":"Kirby D, Ames D (2001) Hyponatraemia and selective serotonin re-uptake inhibitors in elderly patients. Int J Geriatr Psychiatry 16(5):484\u2013493. https:\/\/doi.org\/10.1002\/gps.367","journal-title":"Int J Geriatr Psychiatry"},{"issue":"8","key":"2369_CR33","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1210\/endo.140.8.6891","volume":"140","author":"U Knigge","year":"1999","unstructured":"Knigge U, Willems E, Kjaer A, J\u00f8rgensen H, Warberg J (1999) Histaminergic and catecholaminergic interactions in the central regulation of vasopressin and oxytocin secretion. Endocrinology 140(8):3713\u20133719. https:\/\/doi.org\/10.1210\/endo.140.8.6891","journal-title":"Endocrinology"},{"issue":"11","key":"2369_CR34","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1345\/aph.1G209","volume":"39","author":"GM Kuz","year":"2005","unstructured":"Kuz GM, Manssourian A (2005) Carbamazepine-induced hyponatremia: assessment of risk factors. Ann Pharmacother 39(11):1943\u20131946. https:\/\/doi.org\/10.1345\/aph.1G209","journal-title":"Ann Pharmacother"},{"issue":"6","key":"2369_CR35","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1017\/s1461145711001192","volume":"15","author":"M Letmaier","year":"2012","unstructured":"Letmaier M, Painold A, Holl AK, Vergin H, Engel R, Konstantinidis A, Kasper S, Grohmann R (2012) Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme. Int J Neuropsychopharmacol 15(6):739\u2013748. https:\/\/doi.org\/10.1017\/s1461145711001192","journal-title":"Int J Neuropsychopharmacol"},{"issue":"6","key":"2369_CR36","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1093\/alcalc\/35.6.612","volume":"35","author":"GL Liamis","year":"2000","unstructured":"Liamis GL, Milionis HJ, Rizos EC, Siamopoulos KC, Elisaf MS (2000) Mechanisms of hyponatraemia in alcohol patients. Alcohol Alcohol 35(6):612\u2013616. https:\/\/doi.org\/10.1093\/alcalc\/35.6.612","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"2369_CR37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1053\/j.ajkd.2008.03.004","volume":"52","author":"G Liamis","year":"2008","unstructured":"Liamis G, Milionis H, Elisaf M (2008) A review of drug-induced hyponatremia. Am J Kidney Dis 52(1):144\u2013153. https:\/\/doi.org\/10.1053\/j.ajkd.2008.03.004","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2369_CR38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/WNF.0b013e3181f80bd4","volume":"33","author":"CH Lin","year":"2010","unstructured":"Lin CH, Lu CH, Wang FJ, Tsai MH, Chang WN, Tsai NW, Lai SL, Tseng YL, Chuang YC (2010) Risk factors of oxcarbazepine-induced hyponatremia in patients with epilepsy. Clin Neuropharmacol 33(6):293\u2013296. https:\/\/doi.org\/10.1097\/WNF.0b013e3181f80bd4","journal-title":"Clin Neuropharmacol"},{"issue":"5","key":"2369_CR39","first-page":"519","volume":"155","author":"BA Liu","year":"1996","unstructured":"Liu BA, Mittmann N, Knowles SR, Shear NH (1996) Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports. CMAJ 155(5):519\u2013527","journal-title":"CMAJ"},{"issue":"1-2","key":"2369_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/bf03256181","volume":"21","author":"S Madhusoodanan","year":"2002","unstructured":"Madhusoodanan S, Bogunovic OJ, Moise D, Brenner R, Markowitz S, Sotelo J (2002) Hyponatraemia associated with psychotropic medications. A review of the literature and spontaneous reports. Adverse Drug React Toxicol Rev 21(1\u20132):17\u201329. https:\/\/doi.org\/10.1007\/bf03256181","journal-title":"Adverse Drug React Toxicol Rev"},{"issue":"4","key":"2369_CR41","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.maturitas.2013.08.010","volume":"76","author":"CK Mannesse","year":"2013","unstructured":"Mannesse CK, Jansen PA, Van Marum RJ, Sival RC, Kok RM, Haffmans PM, Egberts TC (2013) Characteristics, prevalence, risk factors, and underlying mechanism of hyponatremia in elderly patients treated with antidepressants: a cross-sectional study. Maturitas 76(4):357\u2013363. https:\/\/doi.org\/10.1016\/j.maturitas.2013.08.010","journal-title":"Maturitas"},{"issue":"6","key":"2369_CR42","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s40263-019-00631-5","volume":"33","author":"F Mazhar","year":"2019","unstructured":"Mazhar F, Pozzi M, Gentili M, Scatigna M, Clementi E, Radice S, Carnovale C (2019) Association of hyponatraemia and antidepressant drugs: a pharmacovigilance-pharmacodynamic assessment through an analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) Database. CNS Drugs 33(6):581\u2013592. https:\/\/doi.org\/10.1007\/s40263-019-00631-5","journal-title":"CNS Drugs"},{"issue":"2","key":"2369_CR43","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/jcp.0000000000001180","volume":"40","author":"F Mazhar","year":"2020","unstructured":"Mazhar F, Carnovale C, Haider N, Ahmed R, Taha M (2020) Paliperidone-associated hyponatremia: report of a fatal case with analysis of cases reported in the literature and to the US Food and Drug Administration Adverse Event Reporting System. J Clin Psychopharmacol 40(2):202\u2013205. https:\/\/doi.org\/10.1097\/jcp.0000000000001180","journal-title":"J Clin Psychopharmacol"},{"key":"2369_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyab005","author":"F Mazhar","year":"2021","unstructured":"Mazhar F, Battini V, Pozzi M, Invernizzi E, Mosini G, Gringeri M, Capuano A, Scavone C, Radice S, Clementi E, Carnovale C (2021) Hyponatraemia following antipsychotic treatment: In-silico pharmacodynamics analysis of spontaneous reports from the US Food and Drug Administration Adverse Event Reporting System Database and an updated systematic review. Int J Neuropsychopharmacol. https:\/\/doi.org\/10.1093\/ijnp\/pyab005","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"2369_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2165\/11319070-000000000-00000","volume":"33","author":"D Meulendijks","year":"2010","unstructured":"Meulendijks D, Mannesse CK, Jansen PA, van Marum RJ, Egberts TC (2010) Antipsychotic-induced hyponatraemia: a systematic review of the published evidence. Drug Saf 33(2):101\u2013114. https:\/\/doi.org\/10.2165\/11319070-000000000-00000","journal-title":"Drug Saf"},{"issue":"4","key":"2369_CR46","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1046\/j.1365-2125.2002.01550.x","volume":"53","author":"KL Movig","year":"2002","unstructured":"Movig KL, Leufkens HG, Lenderink AW, van den Akker VG, Hodiamont PP, Goldschmidt HM, Egberts AC (2002) Association between antidepressant drug use and hyponatraemia: a case\u2013control study. Br J Clin Pharmacol 53(4):363\u2013369. https:\/\/doi.org\/10.1046\/j.1365-2125.2002.01550.x","journal-title":"Br J Clin Pharmacol"},{"key":"2369_CR47","doi-asserted-by":"publisher","first-page":"S264","DOI":"10.14309\/00000434-201510001-00597","volume":"110","author":"J Nachnani","year":"2015","unstructured":"Nachnani J, Bulchandani D, Bulchandani S (2015) Severe hyponatremia associated with the use of pantoprazole. Am J Gastroenterol 110:S264","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"2369_CR48","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/jgs.12767","volume":"62","author":"MI Naharc\u00fd","year":"2014","unstructured":"Naharc\u00fd MI, Cintosun U, Ozturk A, Bozoglu E, Doruk H (2014) Pantoprazole sodium-induced hyponatremia in a frail elderly adult. J Am Geriatr Soc 62(4):787\u2013788. https:\/\/doi.org\/10.1111\/jgs.12767","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"2369_CR49","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/ki.2013.77","volume":"84","author":"S Palmer","year":"2013","unstructured":"Palmer S, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, Pellegrini F, Saglimbene V, Logroscino G, Fishbane S, Strippoli GFM (2013) Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int 84(1):179\u2013191. https:\/\/doi.org\/10.1038\/ki.2013.77","journal-title":"Kidney Int"},{"issue":"4","key":"2369_CR50","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/cpt1979264442","volume":"26","author":"V Peck","year":"1979","unstructured":"Peck V, Shenkman L (1979) Haloperidol-induced syndrome of inappropriate secretion of antidiuretic hormone. Clin Pharmacol Ther 26(4):442\u2013444. https:\/\/doi.org\/10.1002\/cpt1979264442","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"2369_CR51","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/cpt.1562","volume":"106","author":"E Ram\u00edrez","year":"2019","unstructured":"Ram\u00edrez E, Rodr\u00edguez A, Queiruga J, Garc\u00eda I, D\u00edaz L, Mart\u00ednez L, Mu\u00f1oz R, Mu\u00f1oz M, Tong HY, Mart\u00ednez JC, Borobia AM, Carcas AJ, Fr\u00edas J (2019) Severe hyponatremia is often drug induced: 10-year results of a prospective pharmacovigilance program. Clin Pharmacol Ther 106(6):1362\u20131379. https:\/\/doi.org\/10.1002\/cpt.1562","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"2369_CR52","doi-asserted-by":"publisher","first-page":"71.e71","DOI":"10.1016\/j.amjmed.2005.09.026","volume":"119","author":"B Renneboog","year":"2006","unstructured":"Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G (2006) Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 119(1):71.e71-78. https:\/\/doi.org\/10.1016\/j.amjmed.2005.09.026","journal-title":"Am J Med"},{"issue":"2","key":"2369_CR53","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/00000441-200402000-00012","volume":"327","author":"MH Rosner","year":"2004","unstructured":"Rosner MH (2004) Severe hyponatremia associated with the combined use of thiazide diuretics and selective serotonin reuptake inhibitors. Am J Med Sci 327(2):109\u2013111. https:\/\/doi.org\/10.1097\/00000441-200402000-00012","journal-title":"Am J Med Sci"},{"issue":"8","key":"2369_CR54","doi-asserted-by":"publisher","first-page":"453","DOI":"10.5694\/j.1326-5377.2003.tb05635.x","volume":"179","author":"MG Roxanas","year":"2003","unstructured":"Roxanas MG (2003) Mirtazapine-induced hyponatraemia. Med J Aust 179(8):453\u2013454. https:\/\/doi.org\/10.5694\/j.1326-5377.2003.tb05635.x","journal-title":"Med J Aust"},{"issue":"8","key":"2369_CR55","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1111\/bcp.13256","volume":"83","author":"D Shepshelovich","year":"2017","unstructured":"Shepshelovich D, Schechter A, Calvarysky B, Diker-Cohen T, Rozen-Zvi B, Gafter-Gvili A (2017) Medication-induced SIADH: distribution and characterization according to medication class. Br J Clin Pharmacol 83(8):1801\u20131807. https:\/\/doi.org\/10.1111\/bcp.13256","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"2369_CR56","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1001\/archinte.1995.00430090099011","volume":"155","author":"EL Siegler","year":"1995","unstructured":"Siegler EL, Tamres D, Berlin JA, Allen-Taylor L, Strom BL (1995) Risk factors for the development of hyponatremia in psychiatric inpatients. Arch Intern Med 155(9):953\u2013957","journal-title":"Arch Intern Med"},{"issue":"Suppl 2","key":"2369_CR57","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1093\/ndt\/gfu040","volume":"29","author":"G Spasovski","year":"2014","unstructured":"Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, van der Veer S, Van Biesen W, Nagler E (2014) Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant 29(Suppl 2):i1\u2013i39. https:\/\/doi.org\/10.1093\/ndt\/gfu040","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2369_CR58","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2165\/00002018-199512030-00006","volume":"12","author":"O Spigset","year":"1995","unstructured":"Spigset O, Hedenmalm K (1995) Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs. Drug Saf 12(3):209\u2013225. https:\/\/doi.org\/10.2165\/00002018-199512030-00006","journal-title":"Drug Saf"},{"issue":"4","key":"2369_CR59","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/hup.394","volume":"17","author":"CA Stedman","year":"2002","unstructured":"Stedman CA, Begg EJ, Kennedy MA, Roberts R, Wilkinson TJ (2002) Cytochrome P450 2D6 genotype does not predict SSRI (fluoxetine or paroxetine) induced hyponatraemia. Hum Psychopharmacol 17(4):187\u2013190. https:\/\/doi.org\/10.1002\/hup.394","journal-title":"Hum Psychopharmacol"},{"issue":"2","key":"2369_CR60","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3109\/00048679809062743","volume":"32","author":"J Strachan","year":"1998","unstructured":"Strachan J, Shepherd J (1998) Hyponatraemia associated with the use of selective serotonin re-uptake inhibitors. Aust N Z J Psychiatry 32(2):295\u2013298. https:\/\/doi.org\/10.3109\/00048679809062743","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"2369_CR61","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1528-1157.1994.tb02930.x","volume":"35","author":"T Van Amelsvoort","year":"1994","unstructured":"Van Amelsvoort T, Bakshi R, Devaux CB, Schwabe S (1994) Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review. Epilepsia 35(1):181\u2013188. https:\/\/doi.org\/10.1111\/j.1528-1157.1994.tb02930.x","journal-title":"Epilepsia"},{"issue":"1","key":"2369_CR62","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13256-020-02423-8","volume":"14","author":"IJB van der Zalm","year":"2020","unstructured":"van der Zalm IJB, Tob\u00e9 TJM, Logtenberg SJJ (2020) Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report. J Med Case Reports 14(1):83. https:\/\/doi.org\/10.1186\/s13256-020-02423-8","journal-title":"J Med Case Reports"},{"issue":"3","key":"2369_CR63","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1359\/jbmr.090827","volume":"25","author":"JG Verbalis","year":"2010","unstructured":"Verbalis JG, Barsony J, Sugimura Y, Tian Y, Adams DJ, Carter EA, Resnick HE (2010) Hyponatremia-induced osteoporosis. J Bone Miner Res 25(3):554\u2013563. https:\/\/doi.org\/10.1359\/jbmr.090827","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2369_CR64","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/sim.4780120902","volume":"12","author":"SE Vollset","year":"1993","unstructured":"Vollset SE (1993) Confidence intervals for a binomial proportion. Stat Med 12(9):809\u2013824. https:\/\/doi.org\/10.1002\/sim.4780120902","journal-title":"Stat Med"},{"issue":"2","key":"2369_CR65","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1365-2125.1999.00872.x","volume":"47","author":"TJ Wilkinson","year":"1999","unstructured":"Wilkinson TJ, Begg EJ, Winter AC, Sainsbury R (1999) Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people. Br J Clin Pharmacol 47(2):211\u2013217. https:\/\/doi.org\/10.1046\/j.1365-2125.1999.00872.x","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2369_CR66","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1745-7599.2007.00280.x","volume":"20","author":"SK Wright","year":"2008","unstructured":"Wright SK, Schroeter S (2008) Hyponatremia as a complication of selective serotonin reuptake inhibitors. J Am Acad Nurse Pract 20(1):47\u201351. https:\/\/doi.org\/10.1111\/j.1745-7599.2007.00280.x","journal-title":"J Am Acad Nurse Pract"},{"issue":"5","key":"2369_CR67","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00213-017-4525-9","volume":"234","author":"HJ Yang","year":"2017","unstructured":"Yang HJ, Cheng WJ (2017) Antipsychotic use is a risk factor for hyponatremia in patients with schizophrenia: a 15-year follow-up study. Psychopharmacology 234(5):869\u2013876. https:\/\/doi.org\/10.1007\/s00213-017-4525-9","journal-title":"Psychopharmacology"},{"key":"2369_CR067","doi-asserted-by":"publisher","unstructured":"Yip TC, Wong GL, Tse YK, Yuen BW, Luk HW, Lam MH, Li MK, Loo CK, Tsang OT, Tsang SW, Chan HL, Wing YK, Wong VW. High incidence of hepatocellular carcinoma and cirrhotic\ncomplications in patients with psychiatric illness: a territory-wide cohort study. BMC Gastroenterol. 2020;20(1):128. https:\/\/doi.org\/10.1186\/s12876-020-01277-0. PMID: 32349708; PMCID:\nPMC7189713.","DOI":"10.1186\/s12876-020-01277-0"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-021-02369-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-021-02369-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-021-02369-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T13:04:25Z","timestamp":1627563865000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-021-02369-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["2369"],"URL":"https:\/\/doi.org\/10.1007\/s00702-021-02369-1","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"assertion":[{"value":"8 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JS took part in an educational event sponsored by Otsuka\/Lundbeck. ST is a member of the advisory board for Otsuka and Janssen-Cilag and has received speaker\u00b4s honoraria from Janssen-Cilag, Lundbeck\/Otsuka, Recordati Pharma GmbH, and Servier. All other authors state they have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}